Work

A PHASE I/II MULTIPLE DOSE STUDY OF HuM291, A HUMANIZED ANTI-CD3 MONOCLONAL ANTIBODY, IN PATIENTS EXPERIENCING RENAL ALLOGRAFT REJECTION

Year: 1999

Type: article

Source: Transplantation

DOI: 10.1097/00007890-199904150-00651

Authors: Douglas J. Norman, John J. Curtis, Bruce Kaplan, Ken L. Brayman, Arthur J. Matas, Daniel Levitt, Susan E. Light

Institutions: Saint Barnabas Medical Center, University of Minnesota, Oregon Health & Science University, University of Alabama at Birmingham, PDL BioPharma (United States), University of Pennsylvania

Language: English

Topic: Renal Transplantation Outcomes and Treatments

Subfield: Transplantation

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2002028267

FWCI:

Cites:

Cited by:

Related to: 10